Abstract
Bronchiectasis is defined by the presence of abnormal bronchial widening and occurs as a consequence of chronic airway infection. It is an important and common cause of respiratory disease. Antibiotics are the main therapy used for the treatment of this condition. The article will review the use of antibiotics for the treatment of bronchiectasis. Antibiotics can be given as short-term therapy for exacerbations or as long-term/maintenance therapy. Antibiotics given by the inhalational route and macrolides are two relatively new classes of medication that may be useful for long-term therapy. There are significant concerns about the overuse resulting in antibiotic resistance. It should be emphasized that nearly all of the trials in the literature have only had small numbers of subjects. The data that is available describing the use of antibiotics in bronchiectasis can generally be regarded as preliminary.
Keywords: Bronchiectasis, Lung, Inhalational, Macrolide, Antibiotic Resistance, co-existent disease, cystic fibrosis, gentamicin, haemoptysis, debility
Reviews on Recent Clinical Trials
Title: Use of Antibiotics in Bronchiectasis
Volume: 7 Issue: 1
Author(s): Paul T. King and Peter W. Holmes
Affiliation:
Keywords: Bronchiectasis, Lung, Inhalational, Macrolide, Antibiotic Resistance, co-existent disease, cystic fibrosis, gentamicin, haemoptysis, debility
Abstract: Bronchiectasis is defined by the presence of abnormal bronchial widening and occurs as a consequence of chronic airway infection. It is an important and common cause of respiratory disease. Antibiotics are the main therapy used for the treatment of this condition. The article will review the use of antibiotics for the treatment of bronchiectasis. Antibiotics can be given as short-term therapy for exacerbations or as long-term/maintenance therapy. Antibiotics given by the inhalational route and macrolides are two relatively new classes of medication that may be useful for long-term therapy. There are significant concerns about the overuse resulting in antibiotic resistance. It should be emphasized that nearly all of the trials in the literature have only had small numbers of subjects. The data that is available describing the use of antibiotics in bronchiectasis can generally be regarded as preliminary.
Export Options
About this article
Cite this article as:
T. King Paul and W. Holmes Peter, Use of Antibiotics in Bronchiectasis, Reviews on Recent Clinical Trials 2012; 7 (1) . https://dx.doi.org/10.2174/157488712799363280
DOI https://dx.doi.org/10.2174/157488712799363280 |
Print ISSN 1574-8871 |
Publisher Name Bentham Science Publisher |
Online ISSN 1876-1038 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Pursuit of Differentiated Ligands for the Glucocorticoid Receptor
Current Topics in Medicinal Chemistry Selenium-Enriched Yeast: As Selenium Source for Nutritional Purpose
Current Nutrition & Food Science The Role of T and B Cells in Atherosclerosis: Potential Clinical Implications
Current Pharmaceutical Design New Suggestions in Sublingual Immunotherapy for House Dust Mite- Related Allergic Diseases
Current Pharmaceutical Biotechnology The Colostrum Proteome, Ruminant Nutrition and Immunity: A Review
Current Protein & Peptide Science Administration of a Synbiotic to Free-Living Elderly and Evaluation of Serum Cytokines. A Pilot Study
Current Pharmaceutical Design Cytokine and Cytotoxic Signals as Mediators for the Pathogenesis of Severe Cutaneous Adverse Reactions
Current Immunology Reviews (Discontinued) Cytokine Modulation for Anti-Allergic Treatment
Current Pharmaceutical Design A Knock-Down Cell-Based Study for the Functional Analysis of Chloride Intracellular Channel 1 (CLIC1): Integrated Proteomics and Microarray Study
Protein & Peptide Letters Biomarkers in the Exhaled Breath Condensate of Healthy Adults: Mapping the Path Towards Reference Values
Current Medicinal Chemistry Interleukin-17A: A Potential Therapeutic Target in Chronic Lung Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets The Role of Leukotrienes Inhibitors in the Management of Chronic Inflammatory Diseases
Recent Patents on Inflammation & Allergy Drug Discovery Effect of PUFAs Oral Administration on the Amount of Apoptotic Caspases Enzymes in Gastric Cancer Patients Undergoing Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry Monoclonal Antibodies: A Review
Current Clinical Pharmacology High-throughput Genotyping Methods for Pharmacogenomic Studies
Current Pharmacogenomics The Cough Receptor TRPV1 Agonists 15(S)-HETE and LTB4 in the Cough Response to Hypertonicity
Inflammation & Allergy - Drug Targets (Discontinued) Mitochondrial Dysfunction and Antioxidant Therapy in Sepsis
Infectious Disorders - Drug Targets CD147: A Novel Modulator of Inflammatory and Immune Disorders
Current Medicinal Chemistry Vaccine Adjuvants: Key Tools for Innovative Vaccine Design
Current Topics in Medicinal Chemistry Asthma, Allergy and Chemokines
Current Drug Targets